Bittner's syndrome

Stritzler, Conrad

doi:10.1001/archderm.103.5.548

Cited by 6 publications

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Patients with genetic defects associated with depressed cell mediated immunity (CMI) (Wiskott-Aldrich syndrome [26], ataxia telangiectasia [10], Fanconi's anemia [21], dyskeratosis congenita [1], Bittner's syndrome [27], intestinal lymphangiectasia [24], etc), and acquired defects of C M I (common variable hypogammaglobulinemia with C M I deficiency [23], some leukemias and lymphomas [16,21], etc.) have an increased susceptibility to development of multiple, treatment-resistant warts.…”

mentioning

confidence: 99%

Immunopathology of papillomavirus-induced warts and skin cancers in immunodepressed and immunosuppressed patients

Lutzner

1982

Springer Semin Immunopathol

View full text Add to dashboard Cite

Patients with genetic defects associated with depressed cell mediated immunity (CMI) [16,21], etc.) have an increased susceptibility to development of multiple, treatment-resistant warts. Patients who have been inadvertently immunosuppressed by chemotherapeutic drugs, used for malignancies, also have increased wart and skin cancer incidence [20], as do patients who have been purposely immunosuppressed for treatment of auto-or hyperimmune diseases, such as lupus erythematosus [7,20]. Patients who are immunosuppressed over long periods of time to enhance retention of organ transplants, such as renal allograft recipients, also have a high incidence of warts and skin cancers [3,4,7,8,17,20,25]. The cancer incidence in these patients seems to be proportional to the period of immunosup-(

show abstract

mentioning

confidence: 99%